Read our recent posts
- Navigating Dementia Care: Unveiling the GUIDE Model, the Importance of Annual Wellness Visits and Advancements in Alzheimer’s Diagnosis September 27, 2023
- SYNAPS Dx Honors Residents, Families, Staff and Volunteers in Assisted Living Communities September 15, 2023
- Alzheimer’s Disease: Know the Factors, Recognize Opportunities to Reduce Risk September 5, 2023
- SYNAPS Dx President and CEO, Frank Amato, Featured on Business Ninjas Podcast August 7, 2023
- Leqembi, First Drug to Demonstrate Slowed Progression of Alzheimer’s Disease, Earns Full FDA Approval July 12, 2023
- SYNAPS Dx DISCERN™ Test Provides Accurate Diagnosis of Alzheimer’s Disease, Optimizes Prescribing, Minimizes Patient Risks and Informs Coverage Decisions for Leqembi™ July 11, 2023
- Update: FDA Approves Rexulti to Treat Agitation Associated with Alzheimer’s Disease June 27, 2023
- New Recommendation from FDA Advisory Committee: Leqembi Expected to Earn Full FDA Approval to Slow Progression of Alzheimer’s Disease June 25, 2023
- June 21st is the “Longest Day”: Join Us in Raising Awareness of Alzheimer’s Disease June 21, 2023
- SYNAPS Dx President and CEO, Frank Amato, Featured in Surviving Your Brain podcast with Philippe Douyon, MD June 13, 2023
- Donanemab Clinical Trial Data Underscores Need for DISCERN™ Accurate Diagnostic Test for Alzheimer’s Disease, Highlights Physician Shortage in Rural Areas June 13, 2023
- June as Alzheimer’s & Brain Awareness Month Raises Importance of Early Diagnosis June 7, 2023
- Older Americans Month Concludes with Senior Health & Fitness Day May 31, 2023
- New Recommendation from FDA Advisory Committee: Using Rexulti to Treat Agitation Associated with Alzheimer’s Disease May 2, 2023
- Six Ways to Support Cognitive Health for Older Adults May 2, 2023
- The Cost Burdens of Diagnosing and Treating Alzheimer’s Disease: Alarming Issues for Patients, Providers and Payers Nationwide April 3, 2023
- Clinician Alert: Identify the Right Patients at the Right Time for Disease Modifying Therapies to Address Alzheimer’s Disease March 20, 2023
- Seven Ways to Care for Your Brain March 13, 2023
- FDA Approves Alzheimer’s Agent Leqembi Shortly After Release of Congressional Aduhelm Report February 22, 2023
- The Burden of Diagnosis: How physicians confront diagnosing Alzheimer’s disease with influx of patients seeking disease modifying therapies January 29, 2023